Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and High-dose Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT02967276Phase 2Terminated
- Sponsor
- Universidade Estadual de Campinas
- Start
- Jan 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liquid metformin (Aspargo Labs) in multiple myeloma (MM), sponsored by Universidade Estadual de Campinas. Primary endpoint: Response Rate. Started Jan 2017; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02967276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02967276.